No beads. No drop-outs. No problems.

No random marker loss so your critical markers never disappear

Bead array technologies suffer from 5-20% random marker loss each time a bead pool is created. If critical biomarkers or causal variants are lost, rescuing them can be a long, expensive process. Axiom Arrays have no marker loss, so you get every marker you request on every array, every time we make it.

Population, trait, and application-optimized arrays

Generic array designs waste time and budget on redundant and irrelevant markers. You can improve your discovery power by choosing a more efficient array focused on your population and study objectives.

We've developed deep expertise in the design of population-optimized and application-optimized arrays that are now recognized as the state of the art by globally important projects and opinion leaders. Our expertise in using imputation-based marker selection enhances the statistical power of your study by enabling a higher number of variants to be screened at a price suitable for both large and small studies.

 

Enter your information to receive your free poster.

*
*
*
*
*
 
 

Axiom® Biobank Genotyping Arrays offer a choice of population-optimized GWAS marker grids, combined with exome, loss-of-function, ADME, and eQTL markers in one high-coverage, high-value, customizable design.

Axiom® World Arrays combine population-optimized GWAS, replication, fine mapping, and disease gene studies onto one highly efficient array design.

Axiom® miRNA-Target Site Genotyping Arrays are the only arrays that comprehensively cover genomic variation in all parts of the miRNA cascade.

Axiom® Genome-Wide Human Origins 1 Array was designed for the study of human history and natural selection. Its unbiased, well-documented SNP ascertainment strategy enables reliable population-genetic inferences to be made.

Powerful imputation-optimized designs

Imputation is now the standard approach for covering millions of SNPs within limited genotyping budgets, but most investigators are losing 3-4% genomic coverage by imputing from inefficient pairwise tagSNP array designs.

We use proprietary imputation-based SNP selection algorithms to design population-optimized GWAS marker grids that deliver better genomic coverage with fewer array markers.

Axiom® Biobank Genotyping Arrays offer population-optimized GWAS imputation grids, combined with exome, loss-of-function, ADME, and eQTL markers in one high-coverage, high-value, customizable design.

Axiom® World Arrays combine population-optimized GWAS imputation grids, replication, fine mapping, and disease gene studies onto one highly efficient array design.

Flexible, fast, cost-effective array customization

In the past, custom genotyping arrays were expensive, required large sample commitments, and took a lot of time to design and deliver. Investigators are now demanding more custom flexibility.

We have developed the Axiom® myDesign™ pipeline to allow flexible access to custom genotyping for small and large studies. It is supported by a world-class design team for fast design and delivery.

Flexible marker densities with low minimum orders
Custom array contracts usually lock you into thousands of samples on one array design. Axiom myDesign Arrays can be fully customized with 1,500 up to 2.6M markers for as few as 480 samples.

Hundreds of samples can be processed per week on the Axiom 96-sample format using manual or automated protocols. Axiom 384 HT format enables fully automated processing of thousands of samples per week.

Fast, optimized design and manufacture
With over 38 million variants in dbSNP, and de novo markers from your own sequencing, it could take you months to design an optimized array. Or, you can move much faster with our world-class bioinformatics scientists.

With access to the world's largest annotated database of genotype-tested SNPs and indels, we can quickly select from 26 million markers to create your design, add your de novo variants with a very high conversion rate, and manufacture and deliver your array within 6 weeks of your design approval.